Smithfield Trust CO Amgen Inc Transaction History

Smithfield Trust CO

$1.89 Billion
Q1 2024

A detailed history of Smithfield Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Smithfield Trust CO holds 3,438 shares of AMGN stock, worth $1.06 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,438

Previous 3,438 -0.0%

Holding current value

$1.06 Million

Previous $983,000 0.92%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $11,250 - $12,692	-44 Reduced 1.26%	3,438 $983,000
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $19,927 - $23,563	-93 Reduced 2.6%	3,482 $771,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $25,740 - $31,372	114 Added 3.29%	3,575 $860,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $11,451 - $14,550	-50 Reduced 1.42%	3,461 $908,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $8,529 - $9,619	38 Added 1.09%	3,511 $790,000

Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $34,606 - $38,511	-150 Reduced 4.14%	3,473 $844,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $16,308 - $18,663	-82 Reduced 2.21%	3,623 $812,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $21,227 - $24,870	100 Added 2.77%	3,705 $789,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $120,940 - $140,937	-545 Reduced 13.13%	3,605 $896,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $25,316 - $30,147	117 Added 2.9%	4,150 $954,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $10,324 - $11,481	44 Added 1.1%	4,033 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $94,553 - $116,029	478 Added 13.61%	3,989 $941,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $22,233 - $29,487	-122 Reduced 3.36%	3,511 $712,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1,702 - $2,188	-9 Reduced 0.25%	3,633 $876,000
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $17,411 - $20,862	100 Added 2.82%	3,642 $705,000
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $16,836 - $19,736	101 Added 2.94%	3,542 $653,000
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $72,167 - $81,348	-399 Reduced 10.39%	3,441 $654,000
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $68,148 - $79,551	382 Added 11.05%	3,840 $748,000
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $11,673 - $13,160	63 Added 1.86%	3,458 $717,000
Q2 2018 Jul 16, 2018	SELL	$166.05 - $186.51 $34,870 - $39,167	-210 Reduced 5.83%	3,395 $627,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $49,134 - $57,420	-290 Reduced 7.45%	3,605 $614,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $7,257 - $8,109	-43 Reduced 1.09%	3,895 $678,000
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $658,788 - $752,158	3,938	3,938 $734,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Amgen Inc Transaction History